SCHEMBL16851820

SCHEMBL16851820

Cc1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)cc[n+]1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 12/20 0.64
KDR P35968 12/20 0.64
RAF1 P04049 5/20 0.64
RET P07949 3/20 0.64
RIPK2 O43353 2/20 0.64
ABCB11 O95342 2/20 0.64
ABL1 P00519 2/20 0.64
HTR1A P08908 2/20 0.64
PDGFRB P09619 2/20 0.64
ADORA3 P0DMS8 2/20 0.64
KIT P10721 2/20 0.64
FGFR1 P11362 2/20 0.64
PDGFRA P16234 2/20 0.64
FLT1 P17948 2/20 0.64
MAOA P21397 2/20 0.64
EPHA1 P21709 2/20 0.64
TBXA2R P21731 2/20 0.64
EPHA2 P29317 2/20 0.64
TTK P33981 2/20 0.64
EPHX2 P34913 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14751390 0.83 KDR (0.77) BRAFKDRRAF1RETRIPK2
SCHEMBL12333606 0.83 TRPV1 (0.69) BRAFKDRRAF1RETRIPK2
SCHEMBL15114776 0.82 KDR (0.68) BRAFKDRRAF1RETRIPK2
SCHEMBL29746661 0.82 KDR (0.68) BRAFKDRRAF1RETRIPK2
SCHEMBL29746649 0.82 KDR (0.58) BRAFKDRRAF1RETRIPK2
SCHEMBL15114775 0.82 KDR (0.58) BRAFKDRRAF1RETRIPK2
SCHEMBL14714846 0.81 KDR (0.62) BRAFKDRRAF1RETRIPK2
SCHEMBL18615581 0.81 KDR (0.64) BRAFKDRRAF1RETRIPK2
SCHEMBL18615590 0.80 KDR (0.63) BRAFKDRRAF1RETRIPK2
SCHEMBL15140630 0.80 KDR (0.70) BRAFKDRRAF1RETRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175545-A1 Preparation Method of Fluoro-Substituted Deuterated Diphenylurea SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD (CN) 2015-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175545-A1 Preparation Method of Fluoro-Substituted Deuterated Diphenylurea CCND3, UBE2D3, VDR BRAF 1533/4885KDR 4466/4885RAF1 3715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.